Torben Frøstrup Hansen - undervisnings-CV

Torben Frøstrup Hansen

Clinical Associate Professor, IRS, Lillebælt Hospital, Oncology

https://orcid.org/0000-0001-7476-671X

Emailtorben.hansen@slb.regionsyddanmark.dk

If you made any changes in Pure these will be visible here soon.

Personal profile

Research areas

Radiation therapy
Medical treatment
Cancer of the colon
Rectal cancer

Fingerprint Dive into the research topics where Torben Frøstrup Hansen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

24 Similar Profiles

Colorectal Neoplasms Medicine & Life Sciences

MicroRNAs Medicine & Life Sciences

oxaliplatin Medicine & Life Sciences

Colonic Neoplasms Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Single Nucleotide Polymorphism Medicine & Life Sciences

Vascular Endothelial Growth Factor A Medicine & Life Sciences

microRNA Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2020

49 Journal article
15 Poster
5 Conference abstract for conference
5 Conference abstract in journal
7 More

Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer

Zedan, A. H., Osther, P. J. S., Assenholt, J., Madsen, J. S. & Hansen, T. F., 14. Jan 2020, In : Scientific Reports. 10, 9 p., 227.

Research output: Contribution to journal › Journal article › Research › peer-review

Open Access

File

docetaxel

Prostatic Neoplasms

MicroRNAs

abiraterone

102 Downloads (Pure)

Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy

Zedan, A. H., Hansen, T. F., Assenholt, J., Madsen, J. S. & Osther, P. J. S., 1. Mar 2019, In : The Prostate. 79, 4, p. 425-432

Research output: Contribution to journal › Journal article › Research › peer-review

Open Access

File

MicroRNAs

Prostatic Neoplasms

Watchful Waiting

Neoplasm Grading

Real-Time Polymerase Chain Reaction

50 Downloads (Pure)

Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer

Hansen, T. F., Nederby, L., Zedan, A. H., Mejlholm, I., Henriksen, J. R., Dahl Steffensen, K., Thomsen, C. B., Raunkilde, L., Jensen, L. H. & Jakobsen, A., Jul 2019, In : Translational Oncology. 12, 7, p. 968-972

Research output: Contribution to journal › Journal article › Research › peer-review

Open Access

File

Neoplasms

Confidence Intervals

Interferon-gamma

Palliative Care

Ovarian Neoplasms

29 Downloads (Pure)

NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer

Jensen, L. H., Olesen, R., Petersen, L. N., Boysen, A. K., Andersen, R. F., Lindebjerg, J., Nottelmann, L., Thomsen, C. E. B., Havelund, B. M., Jakobsen, A. & Hansen, T. F., 25. Oct 2019, In : Cancers . 11, 11, 13 p., 1649.

Research output: Contribution to journal › Journal article › Research › peer-review

Open Access

File

Neuropeptide Y

Colorectal Neoplasms

DNA

Disease-Free Survival

Confidence Intervals

Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers

Jensen, L. H., Andersen, R. F., Byriel, L., Fernebro, E., Jakobsen, A., Lindebjerg, J., Nottelmann, L., Ploen, J. & Hansen, T. F., 14. Dec 2019, In : Acta oncologica (Stockholm, Sweden). p. 1-4 4 p.

Research output: Contribution to journal › Journal article › Research › peer-review

oxaliplatin

gemcitabine

Disease-Free Survival

Neoplasms

Mutation

Activities 2006 2010

6 Conference organisation or participation
4 Talks and presentations in private or public companies
2 Membership of review committee
1 Membership of commitees, commissions, boards, councils, associations, organisations, or similar